Katrin Burkart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katrin Burkart has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Michael Brauer
University of Washington, Institute for Health Metrics Science, Seattle, Washington, USA
5 shared publicationsPeng Zheng
Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
3 shared publicationsAleksandr Y Aravkin
Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Seattle, WA 98105, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA 98105, USA
2 shared publicationsCharlie Ashbaugh
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
2 shared publicationsChristopher J L Murray
Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Seattle, WA 98105, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA 98105, USA
2 shared publicationsJeffrey D Stanaway
Institute for Health Metrics and Evaluation, School of Medicine, University of Washington, Seattle, WA 98105, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA 98105, USA
2 shared publications
Latest Publications
- Open Access
- 1 November 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 90, 103580
Global, regional and national estimates of the burden of childhood asthma attributable to NO2 exposure for 204 countries and territories from 1990 to 2023: a Global Burden of Disease study 2023
- 1 November 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 90, 103580
Open AccessGlobal, regional and national estimates of the burden of childhood asthma attributable to NO2 exposure for 204 countries and territories from 1990 to 2023: a Global Burden of Disease study 2023
- Open Access
- 16 June 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 85
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
- 16 June 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 85
Open AccessRespiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
- Top Cited PapersOpen Access
- 21 March 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (5) , 897-908
A systematic review with a Burden of Proof meta-analysis of health effects of long-term ambient fine particulate matter (PM2.5) exposure on dementia
Previous studies have indicated increased dementia risk associated with fine particulate matter (PM2.5) exposure; however, the findings are inconsistent. In this systematic review, we assessed the association between long-term PM2.5 exposure and dementia outcomes using the Burden of Proof meta-analytic framework, which relaxes log-linear assumptions to better characterize relative risk functions and quantify unexplained between-study heterogeneity (PROSPERO, ID CRD42023421869). Here we report a meta-analysis of 28 longitudinal cohort studies published up to June 2023 that investigated long-term PM2.5 exposure and dementia outcomes. We derived risk–outcome scores (ROSs), highly conservative measures of effect size and evidence strength, mapped onto a 1–5-star rating from ‘weak and/or inconsistent evidence’ to ‘very strong and/or consistent evidence’. We identified a significant nonlinear relationship between PM2.5 exposure and dementia, with a minimum 14% increased risk averaged across PM2.5 levels between 4.5 and 26.9 µg m−3 (the 15th to 85th percentile exposure range across included studies), relative to a reference of 2.0 µg m−3 (n = 49, ROS = 0.13, two stars). We found a significant association of PM2.5 with Alzheimer’s disease (n = 12, ROS = 0.32, three stars) but not with vascular dementia. Our findings highlight the potential impact of air pollution on brain aging.
- 21 March 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (5) , 897-908
Top Cited PapersOpen AccessA systematic review with a Burden of Proof meta-analysis of health effects of long-term ambient fine particulate matter (PM2.5) exposure on dementia
Previous studies have indicated increased dementia risk associated with fine particulate matter (PM2.5) exposure; however, the findings are inconsistent. In this systematic review, we assessed the association between long-term PM2.5 exposure and dementia outcomes using the Burden of Proof meta-analytic framework, which relaxes log-linear assumptions to better characterize relative risk functions and quantify unexplained between-study heterogeneity (PROSPERO, ID CRD42023421869). Here we report a meta-analysis of 28 longitudinal cohort studies published up to June 2023 that investigated long-term PM2.5 exposure and dementia outcomes. We derived risk–outcome scores (ROSs), highly conservative measures of effect size and evidence strength, mapped onto a 1–5-star rating from ‘weak and/or inconsistent evidence’ to ‘very strong and/or consistent evidence’. We identified a significant nonlinear relationship between PM2.5 exposure and dementia, with a minimum 14% increased risk averaged across PM2.5 levels between 4.5 and 26.9 µg m−3 (the 15th to 85th percentile exposure range across included studies), relative to a reference of 2.0 µg m−3 (n = 49, ROS = 0.13, two stars). We found a significant association of PM2.5 with Alzheimer’s disease (n = 12, ROS = 0.32, three stars) but not with vascular dementia. Our findings highlight the potential impact of air pollution on brain aging.
- Open Access
- 30 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-8
Atmospheric health burden across the century and the accelerating impact of temperature compared to pollution
Anthropogenic emissions alter atmospheric composition and therefore the climate, with implications for air pollution- and climate-related human health. Mortality attributable to air pollution and non-optimal temperature is a major concern, expected to shift under future climate change and socioeconomic scenarios. In this work, results from numerical simulations are used to assess future changes in mortality attributable to long-term exposure to both non-optimal temperature and air pollution simultaneously. Here we show that under a realistic scenario, end-of-century mortality could quadruple from present-day values to around 30 (95% confidence level:12-53) million people/year. While pollution-related mortality is projected to increase five-fold, temperature-related mortality will experience a seven-fold rise, making it a more important health risk factor than air pollution for at least 20% of the world’s population. These findings highlight the urgent need to implement stronger climate policies to prevent future loss of life, outweighing the benefits of air quality improvements alone.
- 30 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-8
Open AccessAtmospheric health burden across the century and the accelerating impact of temperature compared to pollution
Anthropogenic emissions alter atmospheric composition and therefore the climate, with implications for air pollution- and climate-related human health. Mortality attributable to air pollution and non-optimal temperature is a major concern, expected to shift under future climate change and socioeconomic scenarios. In this work, results from numerical simulations are used to assess future changes in mortality attributable to long-term exposure to both non-optimal temperature and air pollution simultaneously. Here we show that under a realistic scenario, end-of-century mortality could quadruple from present-day values to around 30 (95% confidence level:12-53) million people/year. While pollution-related mortality is projected to increase five-fold, temperature-related mortality will experience a seven-fold rise, making it a more important health risk factor than air pollution for at least 20% of the world’s population. These findings highlight the urgent need to implement stronger climate policies to prevent future loss of life, outweighing the benefits of air quality improvements alone.
- Open Access
- 18 November 2022
- Published by Elsevier in eClinicalMedicine
- Vol. 55, 101740
Global, regional and national estimates of influenza-attributable ischemic heart disease mortality
- 18 November 2022
- Published by Elsevier in eClinicalMedicine
- Vol. 55, 101740
Open AccessGlobal, regional and national estimates of influenza-attributable ischemic heart disease mortality
- Top Cited PapersOpen Access
- 6 July 2022
- Published by Elsevier in The Lancet Planetary Health
- Vol. 6 (7) , e586-e600
Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
- 6 July 2022
- Published by Elsevier in The Lancet Planetary Health
- Vol. 6 (7) , e586-e600
Top Cited PapersOpen AccessEstimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
- 17 March 2022
- Published by Elsevier in The Lancet
- Vol. 399 (10330) , 1113-1114
Global mortality burden attributable to non-optimal temperatures – Authors’ reply
- 17 March 2022
- Published by Elsevier in The Lancet
- Vol. 399 (10330) , 1113-1114
Global mortality burden attributable to non-optimal temperatures – Authors’ reply
- Open Access
- 28 September 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (9) , e1003718
Ambient and household PM2.5 pollution and adverse perinatal outcomes: A meta-regression and analysis of attributable global burden for 204 countries and territories
Background: Particulate matter 2.5) is associated with adverse perinatal outcomes, but the impact on disease burden mediated by this pathway has not previously been included in the Global Burden of Disease (GBD), Mortality, Injuries, and Risk Factors studies. We estimated the global burden of low birth weight (LBW) and preterm birth (PTB) and impacts on reduced birth weight and gestational age (GA), attributable to ambient and household PM2.5 pollution in 2019. Methods and findings: We searched PubMed, Embase, and Web of Science for peer-reviewed articles in English. Study quality was assessed using 2 tools: (1) Agency for Healthcare Research and Quality checklist; and (2) National Institute of Environmental Health Sciences (NIEHS) risk of bias questions. We conducted a meta-regression (MR) to quantify the risk of PM2.5 on birth weight and GA. The MR, based on a systematic review (SR) of articles published through April 4, 2021, and resulting uncertainty intervals (UIs) accounted for unexplained between-study heterogeneity. Separate nonlinear relationships relating exposure to risk were generated for each outcome and applied in the burden estimation. The MR included 44, 40, and 40 birth weight, LBW, and PTB studies, respectively. Majority of the studies were of retrospective cohort design and primarily from North America, Europe, and Australia. A few recent studies were from China, India, sub-Saharan Africa, and South America. Pooled estimates indicated 22 grams (95% UI: 12, 32) lower birth weight, 11% greater risk of LBW (1.11, 95% UI: 1.07, 1.16), and 12% greater risk of PTB (1.12, 95% UI: 1.06, 1.19), per 10 μg/m3 increment in ambient PM2.5. We estimated a global population–weighted mean lowering of 89 grams (95% UI: 88, 89) of birth weight and 3.4 weeks (95% UI: 3.4, 3.4) of GA in 2019, attributable to total PM2.5. Globally, an estimated 15.6% (95% UI: 15.6, 15.7) of all LBW and 35.7% (95% UI: 35.6, 35.9) of all PTB infants were attributable to total PM2.5, equivalent to 2,761,720 (95% UI: 2,746,713 to 2,776,722) and 5,870,103 (95% UI: 5,848,046 to 5,892,166) infants in 2019, respectively. About one-third of the total PM2.5 burden for LBW and PTB could be attributable to ambient exposure, with household air pollution (HAP) dominating in low-income countries. The findings should be viewed in light of some limitations such as heterogeneity between studies including size, exposure levels, exposure assessment method, and adjustment for confounding. Furthermore, studies did not separate the direct effect of PM2.5 on birth weight from that mediated through GA. As a consequence, the pooled risk estimates in the MR and likewise the global burden may have been underestimated. Conclusions: Ambient and household PM2.5 were associated with reduced birth weight and GA, which are, in turn, associated with neonatal and infant mortality, particularly in low- and middle-income countries.
- 28 September 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (9) , e1003718
Open AccessAmbient and household PM2.5 pollution and adverse perinatal outcomes: A meta-regression and analysis of attributable global burden for 204 countries and territories
Background: Particulate matter 2.5) is associated with adverse perinatal outcomes, but the impact on disease burden mediated by this pathway has not previously been included in the Global Burden of Disease (GBD), Mortality, Injuries, and Risk Factors studies. We estimated the global burden of low birth weight (LBW) and preterm birth (PTB) and impacts on reduced birth weight and gestational age (GA), attributable to ambient and household PM2.5 pollution in 2019. Methods and findings: We searched PubMed, Embase, and Web of Science for peer-reviewed articles in English. Study quality was assessed using 2 tools: (1) Agency for Healthcare Research and Quality checklist; and (2) National Institute of Environmental Health Sciences (NIEHS) risk of bias questions. We conducted a meta-regression (MR) to quantify the risk of PM2.5 on birth weight and GA. The MR, based on a systematic review (SR) of articles published through April 4, 2021, and resulting uncertainty intervals (UIs) accounted for unexplained between-study heterogeneity. Separate nonlinear relationships relating exposure to risk were generated for each outcome and applied in the burden estimation. The MR included 44, 40, and 40 birth weight, LBW, and PTB studies, respectively. Majority of the studies were of retrospective cohort design and primarily from North America, Europe, and Australia. A few recent studies were from China, India, sub-Saharan Africa, and South America. Pooled estimates indicated 22 grams (95% UI: 12, 32) lower birth weight, 11% greater risk of LBW (1.11, 95% UI: 1.07, 1.16), and 12% greater risk of PTB (1.12, 95% UI: 1.06, 1.19), per 10 μg/m3 increment in ambient PM2.5. We estimated a global population–weighted mean lowering of 89 grams (95% UI: 88, 89) of birth weight and 3.4 weeks (95% UI: 3.4, 3.4) of GA in 2019, attributable to total PM2.5. Globally, an estimated 15.6% (95% UI: 15.6, 15.7) of all LBW and 35.7% (95% UI: 35.6, 35.9) of all PTB infants were attributable to total PM2.5, equivalent to 2,761,720 (95% UI: 2,746,713 to 2,776,722) and 5,870,103 (95% UI: 5,848,046 to 5,892,166) infants in 2019, respectively. About one-third of the total PM2.5 burden for LBW and PTB could be attributable to ambient exposure, with household air pollution (HAP) dominating in low-income countries. The findings should be viewed in light of some limitations such as heterogeneity between studies including size, exposure levels, exposure assessment method, and adjustment for confounding. Furthermore, studies did not separate the direct effect of PM2.5 on birth weight from that mediated through GA. As a consequence, the pooled risk estimates in the MR and likewise the global burden may have been underestimated. Conclusions: Ambient and household PM2.5 were associated with reduced birth weight and GA, which are, in turn, associated with neonatal and infant mortality, particularly in low- and middle-income countries.
- Top Cited PapersOpen Access
- 1 August 2021
- Published by Elsevier in The Lancet
- Vol. 398 (10301) , 685-697
Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study
- 1 August 2021
- Published by Elsevier in The Lancet
- Vol. 398 (10301) , 685-697
Top Cited PapersOpen AccessEstimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study